Other headlinesIntelerad customer base surges
GE adds intracardiac echo catheters
The Vividi and Vividq ultrasound systems from GE Healthcare now can be equipped with intracardiac echo (ICE) catheters from Biosense Webster. Vividi systems with version BT10 software support the Biosense Webster AcuNav 8F ICE catheter, featuring a 33% smaller cross sectional area than the AcuNav 10F catheter. Vividi and Vividq systems are also compatible with the SoundStar 3D ICE catheters, as well as with the Biosense Webster CartoXP system with the CartoSound version 9.7 software module. CartoSound and the SoundStar 3D catheters integrate real-time intracardiac echocardiography imaging, enhancing visualization and navigational confidence during complex EP procedures.
Intelerad customer base surges
Orders and installations in the U.S., Australia, and Canada have expanded the customer base of PACS/IT vendor Intelerad Medical Systems. More than a dozen sites have recently signed up for PACS and workflow management products from Intelerad, according to the company. Among them are St. Vincent General Hospital District of Leadville, CO; Ultrasound Care of Sydney; and Breast Centre Radiology in Edmonton.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.